{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:17:49Z","timestamp":1758845869518,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2014,7,15]]},"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>The only method currently available to perform <jats:italic>Neisseria gonorrhoeae<\/jats:italic> antimicrobial susceptibility testing (Ng-AST) requires a viable organism obtained by culture. Reports of in vitro resistance to extended-spectrum cephalosporins, the treatment of choice for gonorrhoea, coupled with increasing gonorrhoea diagnoses is worrying. The aim of this study was to identify various methodologies employed by the UK microbiology laboratories to perform Ng-AST. Of the 118 laboratories that responded, 114 offered Ng-AST; the majority (82.5%, 94\/114) of the laboratories used British Society for Antimicrobial Chemotherapy methodology for Ng-AST. The other main findings were infrequent use of quality control procedures and inconsistent susceptibility testing of the antibiotics used routinely for treatment.<\/jats:p>","DOI":"10.1136\/jclinpath-2014-202392","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T23:07:03Z","timestamp":1406761623000},"page":"1013-1016","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["An evaluation of <i>Neisseria gonorrhoeae<\/i> antimicrobial susceptibility testing in the UK"],"prefix":"10.1136","volume":"67","author":[{"given":"Anu","family":"Jain","sequence":"first","affiliation":[{"name":"Sexually Transmitted Bacteria Reference Unit, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J","family":"Cole","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Bacteria Reference Unit, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Planche","sequence":"additional","affiliation":[{"name":"St. George's University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A","family":"Ison","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Bacteria Reference Unit, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"2025092505365584000_67.11.1013.1","unstructured":"Public Health England. Sexually transmitted infections and chlamydia screening in England, 2012. 2013. http:\/\/www.hpa.org.uk\/hpr\/archives\/2013\/hpr2313.pdf (accessed 16 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.2","unstructured":"Health Protection Agency. Gonoccocal Resistance to Antimicrobials Surveillance Programme (GRASP) action plan for England and Wales: informing the public health response. 2013. http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1317138215954 (accessed 16 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.3","unstructured":"World Health Organization, Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012. http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf (accessed 16 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.4.463"},{"key":"2025092505365584000_67.11.1013.5","unstructured":"British Society for Antimicrobial chemotherapy. BSAC Methods for Antimicrobial Susceptibility Testing Version 12. 2013. http:\/\/bsac.org.uk\/. http:\/\/bsac.org.uk\/wp-content\/uploads\/2012\/02\/Version-12-Apr-2013_final.pdf (accessed 16 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.6","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-Ninth Edition. CLSI document M07-A9."},{"key":"2025092505365584000_67.11.1013.7","unstructured":"Unemo M Ballard R Ison C . Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85343\/1\/9789241505840_eng.pdf (accessed 19 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"2025092505365584000_67.11.1013.9","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. 2014. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_4.0.pdf (accessed 19 Feb 2014)."},{"key":"2025092505365584000_67.11.1013.10","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.011267"},{"key":"2025092505365584000_67.11.1013.11","unstructured":"British Society for Antimicrobial Chemotherapy. Common questions on antimicrobial susceptibility testing. http:\/\/bsac.org.uk\/wp-content\/uploads\/2012\/02\/FAQ.pdf (accessed 20 Aug 2013)."},{"key":"2025092505365584000_67.11.1013.12","unstructured":"British Society for Antimicrobial Chemotherapy. Use of gradient tests for determination of MICs by BSAC methodology. http:\/\/bsac.org.uk\/wp-content\/uploads\/2012\/02\/Use-of-gradient-tests.pdf (accessed 24 Oct 2013)."},{"key":"2025092505365584000_67.11.1013.13","unstructured":"British Society for Antimicrobial chemotherapy. Agar medium for antimicrobial susceptibility testing of Neisseria gonorrhoeae. http:\/\/bsac.org.uk\/wp-content\/uploads\/2014\/06\/Neisseria-gonorrhoeae.pdf (accessed 29 Jun 2014)."}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2014-202392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:37:08Z","timestamp":1758803828000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2014-202392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":13,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,16]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1136\/jclinpath-2014-202392"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2014-202392","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2014,7,30]]}}}